Literature DB >> 11675083

Peripheral arterial disease.

K Ouriel1.   

Abstract

Lower extremity peripheral arterial disease (PAD) most frequently presents with pain during ambulation, which is known as "intermittent claudication". Some relief of symptoms is possible with exercise, pharmacotherapy, and cessation of smoking. The risk of limb-loss is overshadowed by the risk of mortality from coexistent coronary artery and cerebrovascular atherosclerosis. Primary therapy should be directed at treating the generalised atherosclerotic process, managing lipids, blood sugar, and blood pressure. By contrast, the risk of limb-loss becomes substantial when there is pain at rest, ischaemic ulceration, or gangrene. Interventions such as balloon angioplasty, stenting, and surgical revascularisation should be considered in these patients with so-called "critical limb ischaemia". The choice of the intervention is dependent on the anatomy of the stenotic or occlusive lesion; percutaneous interventions are appropriate when the lesion is focal and short but longer lesions must be treated with surgical revascularisation to achieve acceptable long-term outcome.

Entities:  

Mesh:

Year:  2001        PMID: 11675083     DOI: 10.1016/S0140-6736(01)06351-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  137 in total

1.  Fast plaque burden assessment of the femoral artery using 3D black-blood MRI and automated segmentation.

Authors:  Bernard Chiu; Jie Sun; Xihai Zhao; Jinnan Wang; Niranjan Balu; Jiachang Chi; Jianrong Xu; Chun Yuan; William S Kerwin
Journal:  Med Phys       Date:  2011-10       Impact factor: 4.071

Review 2.  Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.

Authors:  Luqia Hou; Joseph J Kim; Y Joseph Woo; Ngan F Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-12-18       Impact factor: 4.733

Review 3.  Peripheral arterial disease in diabetes: is there a role for genetics?

Authors:  Arabindra B Katwal; Ayotunde O Dokun
Journal:  Curr Diab Rep       Date:  2011-06       Impact factor: 4.810

Review 4.  The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function.

Authors:  Kyra E Pyke; Michael E Tschakovsky
Journal:  J Physiol       Date:  2005-07-28       Impact factor: 5.182

Review 5.  Modulating the vascular response to limb ischemia: angiogenic and cell therapies.

Authors:  John P Cooke; Douglas W Losordo
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

6.  Fatigability and functional performance among older adults with low-normal ankle-brachial index: Cross-sectional findings from the Baltimore Longitudinal Study of Aging.

Authors:  Pablo Martinez-Amezcua; Kunihiro Matsushita; Eleanor M Simonsick; Luigi Ferrucci; Jennifer A Schrack
Journal:  Atherosclerosis       Date:  2018-03-22       Impact factor: 5.162

7.  Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.

Authors:  S Gadau; C Emanueli; S Van Linthout; G Graiani; M Todaro; M Meloni; I Campesi; G Invernici; F Spillmann; K Ward; P Madeddu
Journal:  Diabetologia       Date:  2006-01-17       Impact factor: 10.122

8.  Percutaneous treatment of complete chronic occlusions of the superficial femoral artery.

Authors:  D Laganà; G Carrafiello; M Dizonno; M Barresi; R Caronno; P Castelli; C Fugazzola
Journal:  Radiol Med       Date:  2008-05-20       Impact factor: 3.469

9.  Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions.

Authors:  Brian G DeRubertis; Peter L Faries; James F McKinsey; Rabih A Chaer; Matthew Pierce; John Karwowski; Alan Weinberg; Roman Nowygrod; Nicholas J Morrissey; Harry L Bush; K Craig Kent
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

10.  A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemia.

Authors:  Ayotunde O Dokun; Sehoon Keum; Surovi Hazarika; Yongjun Li; Gregory M Lamonte; Ferrin Wheeler; Douglas A Marchuk; Brian H Annex
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.